Home
Dashboard
Curated content
Themes
Innovations
Key Innovators
Key Innovators - Universities
European Innovation Council
Funding rounds
Companies
Corporates
Investors
Jobs
Support Organisations
Events
Investment heatmap
Matching tool
Companies
Modis Therapeutics
Save
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Launch date
2016
Market cap
-
Enterprise valuation
CAD341m
(Public information from Aug 2019)
Oakland California (HQ)
http://modistx.com
B2B
manufacturing
health
hard tech
biotechnology
biotech and pharma
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (69)
Modis Therapeutics funding
Modis Therapeutics investors
Edit
Date
Investors
Amount
Round
-
Eight Roads Ventures
N/A
-
Oct 2018
OrbiMed
F-Prime
$30.0m
Series A
Aug 2019
Zogenix
$250m
Valuation: $250m
Acquisition
Total Funding
CAD40.9m
Related Content
Recent News about Modis Therapeutics
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
Login for access